| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |